# Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients

> **NCT03409315** · — · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 360 (estimated)

## Conditions studied

- Tuberculosis, Multidrug-Resistant

## Interventions

- **PROCEDURE:** Centralized Therapeutic Drug Monitoring

## Key facts

- **NCT ID:** NCT03409315
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-10
- **Primary completion:** 2020-11
- **Final completion:** 2020-12
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2019-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03409315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03409315, "Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03409315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*